The Philadelphia Inquirer writes there are other, lesser-known risk genes for breast cancer beyond the BRCA genes.
"BRCA1 and BRCA2 are the tip of the iceberg," Penn Medicine's Angela Bradbury tells the paper. "There are many other mutations."
...and receive Daily News bulletins.
Already have an account?Login Now.
Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.
The Wall Street Journal looks into the cost of new gene therapies.
An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.
In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.